|
|
| Line 1,020: |
Line 1,020: |
| *[[Division of Cancer Epidemiology and Genetics]] | | *[[Division of Cancer Epidemiology and Genetics]] |
| *[[United States Census of Agriculture]] | | *[[United States Census of Agriculture]] |
| * | | *[[Center for Cancer Research]] - https://ccr.cancer.gov/ |
|
| |
|
| == Organization ==
| | * [[Division of Cancer Epidemiology and Genetics]] - https://dceg.cancer.gov/ |
| The NCI is divided into several divisions and centers.<ref>{{cite web|url=https://www.cancer.gov/about-nci/organization#divisions|title=NCI Organization|website=National Cancer Institute|date=1980-01-01}}</ref>
| | * [[Division of Cancer Biology]] |
| | * [[Physical Sciences-Oncology Centers|Physical Sciences-Oncology Network]] |
| | * [[Cancer Systems Biology Consortium]] |
| | * [[Oncology Models Forum]] |
| | * [[Barrett's Esophagus Translational Research Network]] |
| | * [[New Approaches to Synthetic Lethality for Mutant KRAS-Dependent Cancers]] |
| | * [[Molecular and Cellular Characterization of Screen-Detected Lesions]] |
| | * [[Fusion Oncoproteins in Childhood Cancers]] |
| | * [[Cancer Tissue Engineering Collaborative]]<ref>{{cite web|url=https://www.cancer.gov/about-nci/organization/dcb|title=Division of Cancer Biology|website=National Cancer Institute|date=2016-08-08}}</ref> |
|
| |
|
| === Intramural ===
| |
| * [[Center for Cancer Research]]
| |
| ** https://ccr.cancer.gov/
| |
| ** The CCR includes approximately 250 internal NCI research groups in Frederick and Bethesda.<ref>{{cite web|url=https://ccr.cancer.gov/about|title=About CCR|date=21 July 2014}}</ref>
| |
|
| |
| * [[Division of Cancer Epidemiology and Genetics]]
| |
| ** https://dceg.cancer.gov/
| |
| ** DCEG is made up of eight branches within the Trans-divisional Research Program.<ref>{{cite web|url=http://dceg.cancer.gov|title=DCEG Home|website=Division of Cancer Epidemiology and Genetics – National Cancer Institute|date=1980-01-01}}</ref>
| |
| === Extramural ===
| |
| * [[Division of Cancer Biology]]
| |
| ** DCB oversees approximately 2000 grants per year in the areas of cancer cell biology; cancer immunology, hematology, and etiology; DNA and chromosome aberrations; structural biology and molecular applications; tumor biology and microenvironment; and tumor metastasis.<ref>{{cite web|url=https://www.cancer.gov/about-nci/organization/dcb/research-portfolio|title=DCB Research Portfolio|website=National Cancer Institute|date=2016-08-08}}</ref>
| |
| ** Special Research Programs falling under the aegis of the DCB include:
| |
| *** [[Physical Sciences-Oncology Centers|Physical Sciences-Oncology Network]]
| |
| *** [[Cancer Systems Biology Consortium]]
| |
| *** [[Oncology Models Forum]]
| |
| *** [[Barrett's Esophagus Translational Research Network]]
| |
| *** [[New Approaches to Synthetic Lethality for Mutant KRAS-Dependent Cancers]]
| |
| *** [[Molecular and Cellular Characterization of Screen-Detected Lesions]]
| |
| *** [[Fusion Oncoproteins in Childhood Cancers]]
| |
| *** [[Cancer Tissue Engineering Collaborative]]<ref>{{cite web|url=https://www.cancer.gov/about-nci/organization/dcb|title=Division of Cancer Biology|website=National Cancer Institute|date=2016-08-08}}</ref>
| |
| * [[Division of Cancer Control and Population Sciences]] | | * [[Division of Cancer Control and Population Sciences]] |
| * [[Division of Cancer Prevention]] | | * [[Division of Cancer Prevention]] |
| * [[Division of Cancer Treatment and Diagnosis]] | | * [[Division of Cancer Treatment and Diagnosis]] |
| ** DCTD supports eight research programs:
| | * [[Biometric Research Program]] |
| *** [[Biometric Research Program]]
| | * [[Cancer Diagnosis Program]] |
| *** [[Cancer Diagnosis Program]]
| | * [[Cancer Imaging Program]] |
| *** [[Cancer Imaging Program]]
| | * [[Cancer Therapy Evaluation Program]] |
| *** [[Cancer Therapy Evaluation Program]]
| | * [[Developmental Therapeutics Program]] |
| *** [[Developmental Therapeutics Program]]
| | * [[Radiation Research Program]] |
| *** [[Radiation Research Program]]
| | * [[Translational Research Program]] |
| *** [[Translational Research Program]]
| | * [[Office of Cancer Complementary and Alternative Medicine]] - https://dctd.cancer.gov/About/default.htm |
| *** [[Office of Cancer Complementary and Alternative Medicine]].<ref>{{cite web|url=https://dctd.cancer.gov/About/default.htm|title=About DCTD – DCTD|website=dctd.cancer.gov}}</ref>
| |
| * [[Division of Extramural Activities]] | | * [[Division of Extramural Activities]] |
| ** DEA processes and supports the thousands of grant applications NCI receives each year and compiles reports on the progress of research funded by the NCI's programs.<ref>{{cite web|url=https://deainfo.nci.nih.gov/aboutDEA.htm|title=About NCI Division of Extramural Activities|website=deainfo.nci.nih.gov}}</ref>
| |
|
| |
| === Office of the director ===
| |
| * [[Center for Biomedical Informatics and Information Technology]] | | * [[Center for Biomedical Informatics and Information Technology]] |
| * [[Center for Cancer Genomics]] | | * [[Center for Cancer Genomics]] |
| ** CCG was created in 2011 and is responsible for management of the [[Cancer Genome Atlas]] and cancer genomics initiatives.
| |
| * [[Center for Cancer Training]] | | * [[Center for Cancer Training]] |
| * [[Center for Global Health]] | | * [[Center for Global Health]] |
| * [[Center for Strategic Scientific Initiatives]] | | * [[Center for Strategic Scientific Initiatives]] |
| ** In the 1990s, the Unconventional Innovation Program was created to integrate interdisciplinary technology research with biological applications. It was reorganized in 2004 as the CSSI.<ref>{{cite web|url=https://cssi.cancer.gov/about/history|title=History – Center for Strategic Scientific Initiatives (CSSI)|website=cssi.cancer.gov|access-date=2017-09-28|archive-date=2017-09-29|archive-url=https://web.archive.org/web/20170929001136/https://cssi.cancer.gov/about/history|url-status=dead}}</ref>
| |
| * [[Center to Reduce Cancer Health Disparities]] | | * [[Center to Reduce Cancer Health Disparities]] |
| * [[Center for Research Strategy]] | | * [[Center for Research Strategy]] |
| * [[Coordinating Center for Clinical Trials]] | | * [[Coordinating Center for Clinical Trials]] |
| * [[Technology Transfer Center]] | | * [[Technology Transfer Center]] |
|
| |
| == Acts == | | == Acts == |
| * [[National Arthritis Act of 1974]] | | * [[National Arthritis Act of 1974]] |